Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2<sup>V617F</sup>-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study. [PDF]
Front OncolChang L, Li WX, Cai H, Li J, Duan MH.
europepmc +1 more source
Reversibility of acrocyanosis and improvement of capillaroscopic pattern in a patient with polycythemia vera treated with ruxolitinib: a case report. [PDF]
Blood ResNigro A.
europepmc +1 more source
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study. [PDF]
Int J CancerYoon SY +15 more
europepmc +1 more source
Arterial Stiffness as a New Predictor of Clinical Outcome in Patients with Polycythemia Vera. [PDF]
J Clin MedMulas O +9 more
europepmc +1 more source
Correction: Hemorrhagic Stroke in a 24-Year-Old Male With Polycythemia Vera: A Case Report and Literature Review. [PDF]
CureusRivera JM, Opinaldo PV.
europepmc +1 more source
Resource utilization and inpatient hospitalization costs associated with thromboembolic events among patients with polycythemia vera. [PDF]
OncologistYu J +6 more
europepmc +1 more source
Distal Internal Carotid Artery Thrombus in Polycythemia Vera. [PDF]
Intern MedArai N, Kato Y, Nakagami T, Suda S.
europepmc +1 more source
The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis [PDF]
Boque, Concepción +4 more
core +1 more source